Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis
Jiayu Ling(Sun Yat-sen University), Yanhong Deng(Sun Yat-sen University), Huai‐Ming Wang(Sun Yat-sen University), Lishuo Shi(Sun Yat-sen University), Miaomiao Ding(Sun Yat-sen University), Hui Wang(Sun Yat-sen University), Jianwei Zhang(Capital Medical University), Huabin Hu(Sun Yat-sen University), Yue Cai(Sun Yat-sen University), Wuteng Cao(Sun Yat-sen University), Xiaoyu Xie(Nanjing Agricultural University), Zi‐Feng Yang(Sun Yat-sen University), Yandong Zhao(Sun Yat-sen University)
Cited by 13
Related Papers
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
|Journal of Clinical Oncology|2016|409
BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
|Nature|2017|402